Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study.
Rachel M EngenPatricia L WengWeiwen ShihHiren P PatelKelsey L RichardsonShauna L DowdrickIsa F AshoorJason M MisuracAvram Z TraumMichael G SemanikNamarata G JainAsifhusen MansuriRajasree SreedharanPublished in: Pediatric transplantation (2021)
G-CSF use for neutropenia in pediatric kidney transplant recipients did not shorten the overall duration of neutropenia but was associated with lower risk of hospitalization. Prospective studies are needed to determine which patients may benefit from G-CSF treatment.